Pembrolizumab was associated with high response rates in surgically unresectable advanced desmoplastic melanoma.

Pembrolizumab showed an 89% objective response rate in unresectable desmoplastic melanoma, with a 37% complete response rate.

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system ...

This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can ...

Desmoplastic melanoma (DM) is a rare subtype of melanoma which carries a high tumor mutation burden and is found in highly sun-exposed areas. Although many cutaneous melanomas are pigmented, DM is ...

Amelanotic melanoma: the great masquerader. J Am Acad Dermatol. 2000;42 (5 Pt 1):731-734. Elmets CA, Ceilley RI. Amelanotic melanoma presenting as pyogenic granuloma. Cutis. 1980;25:164-166, 168.

Purpose Previous studies have established that patients with desmoplastic melanoma (DM) have thicker primary tumors. Consequently, comparisons with other forms of melanoma have been strongly biased by ...